Viewing Study NCT00002434



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00002434
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia PCP
Sponsor: US Bioscience
Organization: NIH AIDS Clinical Trials Information Service

Study Overview

Official Title: A Study of Trimetrexate Glucuronate Neutrexin With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia
Status: COMPLETED
Status Verified Date: 1994-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the safety and efficacy of trimetrexate glucuronate with leucovorin protection in patients with Pneumocystis carinii pneumonia PCP who are refractory to or have demonstrated severe or life-threatening toxicities to standard therapies eg TMPSMX or parenteral pentamidine
Detailed Description: Patients receive intravenous infusions of trimetrexate glucuronate and leucovorin for 21 days Leucovorin is continued for 3 additional days after discontinuation of trimetrexate glucuronate Patients are followed for 1 month

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
TMTX 0014 None None None